Salvage radiotherapy for biochemical relapse after complete PSA response following radical prostatectomy: Outcome and prognostic factors for patients who have never received hormonal therapy

Radiation Oncology

Volumn 2, Issue 1, 2007, Pages

  Jacinto, Alexandre A ^a   Fede, Angelo B S ^a   Fagundes, Lívia A ^a   Salvajoli, João V ^a   Castilho, Marcus S ^a   Viani, Gustavo A ^a   Fogaroli, Ricardo C ^a   Novaes, Paulo E R S ^a   Pellizzon, Antonio Cássio A ^a   Maia, Maria A C ^a   Ferrigno, Robson ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BLOOD; FOLLOW UP; HUMAN; MAGNETIC AND ELECTROMAGNETIC EQUIPMENT; MALE; MIDDLE AGED; PROGNOSIS; PROSTATE TUMOR; PROSTATECTOMY; SALVAGE THERAPY; TIME; TREATMENT OUTCOME;

AGED; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PARTICLE ACCELERATORS; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SALVAGE THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 34248397121     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-2-8     Document Type: Article

References (41)

1. Pound CR Partin AW Eisenberger MA Chan DW Pearson JD Walsh PC Natural history of progression after PSA elevation following radical prostatectomy JAMA 1999 281 1591-1597 10.1001/jama.281.17.1591 10235151
2. Jhaveri FM Zippe CD Klein EA Kupelian PA Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results Urology 1999 54 884-890 10.1016/ S0090-4295(99)00252-6 10565752
3. Bianco FJ Jr. Wood DP Jr. Cher ML Powell IJ Souza JW Pontes JE Ten-year survival after radical prostatectomy: Specimen Gleason score is the predictor in organ-confined prostate cancer Clin Prostate Cancer 2003 1 242-247 15040883
4. Hull GW Rabbani F Abbas F Wheeler TM Kattan MW Scardino PT Cancer control with radical prostatectomy alone in 1,000 consecutive patients J Urol 2002 167 528-534 10.1016/S0022-5347(01)69079-7 11792912
5. Pound CR Partin AW Epstein JI Walsh PC Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control Urol Clin North Am 1997 24 395-406 10.1016/ S0094-0143(05)70386-4 9126237
6. Zincke H Oesterling JE Blute ML Bergstralh EJ Myers RP Barrett DM Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer J Urol 1994 152 1850-1857 7523733
7. Amling CL Bergstralh EJ Blute ML Slezak JM Zincke H Defining prostate specific antigen progression after radical prostatectomy: What is the most appropriate cut point? J Urol 2001 165 1146-1151 10.1016/ S0022-5347(05)66452-X 11257657
8. Bolla M van Poppel H Collette L van Cangh P Vekemans K Da Pozzo L de Reijke TM Verbaeys A Bosset JF van Velthoven R Marechal JM Scalliet P Haustermans K Pierart M Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911) Lancet 2005 366 572-578 10.1016/S0140-6736(05)67101-2 16099293
9. Stephenson AJ Shariat SF Zelefsky MJ Kattan MW Butler EB Teh BS Klein EA Kupelian PA Roehrborn CG Pistenmaa DA Pacholke HD Liauw SL Katz MS Leibel SA Scardino PT Slawin KM Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy JAMA 2004 291 1325-1332 10.1001/jama.291.11.1325 15026399
10. Walsh PC Partin AW Epstein JI Cancer control and quality of life following anatomical radical retropubic prostatectomy: Results at 10 years J Urol 1994 152 1831-1836 7523730
11. Gerber GS Thisted RA Scardino PT Frohmuller HG Schroeder FH Paulson DF Middleton AW Jr. Rukstalis DB Smith JA Jr. Schellhammer PF Ohori M Chodak GW Results of radical prostatectomy in men with clinically localized prostate cancer JAMA 1996 276 615-619 10.1001/jama.276.8.615 8773633
12. Catalona WJ Smith DS Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: Intermediate-term results J Urol 1998 160 2428-2434 10.1016/S0022-5347(01)62204-3 9817397
13. Wu JJ King SC Montana GS McKinstry CA Anscher MS The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen Int J Radiat Oncol Biol Phys 1995 32 317-323 10.1016/0360-3016(95)00083-B 7538500
14. Valicenti RK Gomella LG Ismail M Mulholland SG Strup S Petersen RO Corn BW Lu JD Durable efficacy of early postoperative radiation therapy for high-risk pT3N0 prostate cancer: The importance of radiation dose Urology 1998 52 1034-1040 10.1016/S0090-4295(98)00405-1 9836551
15. Song DY Thompson TL Ramakrishnan V Harrison R Bhavsar N Onaodowan O DeWeese TL Salvage radiotherapy for rising or persistent PSA after radical prostatectomy Urology 2002 60 281-287 10.1016/ S0090-4295(02)01709-0 12137827
16. Rogers R Grossfeld GD Roach M III Shinohara K Presti JC Jr. Carroll PR Radiation therapy for the management of biopsy proved local recurrence after radical prostatectomy J Urol 1998 160 1748-1753 10.1016/ S0022-5347(01)62398-X 9783945
17. Ravery V Lamotte F Hennequin CH Toublanc M Boccon-Gibod L Hermieu JF Delmas V Boccon-Gibod L Adjuvant radiation therapy for recurrent PSA after radical prostatectomy in T1-T2 prostate cancer Prostate Cancer Prostatic Dis 1998 1 321-325 10.1038/sj.pcan.4500261 12496874
18. Pisansky TM Kozelsky TF Myers RP Hillman DW Blute ML Buskirk SJ Cheville JC Ferrigni RG Schild SE Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer J Urol 2000 163 845-850 10.1016/S0022-5347(05)67817-2 10687990
19. Liauw SL Webster WS Pistenmaa DA Roehrborn CG Salvage radiotherapy for biochemical failure of radical prostatectomy: A single-institution experience Urology 2003 61 1204-1210 10.1016/S0090-4295(03)00044-X 12809898
20. Leventis AK Shariat SF Kattan MW Butler EB Wheeler TM Slawin KM Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy J Clin Oncol 2001 19 1030-1039 11181666
21. Koppie TM Grossfeld GD Nudell DM Weinberg VK Carroll PR Is anastomotic biopsy necessary before radiotherapy after radical prostatectomy? J Urol 2001 166 111-115 10.1016/S0022-5347(05)66087-9 11435834
22. Forman JD Duclos M Shamsa F Pontes EJ Predicting the need for adjuvant systemic therapy in patients receiving postprostatectomy irradiation Urology 1996 47 382-386 10.1016/S0090-4295(99)80457-9 8633406
23. Eulau SM Tate DJ Stamey TA Bagshaw MA Hancock SL Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer Int J Radiat Oncol Biol Phys 1998 41 735-740 10.1016/S0360-3016(98)00127-8 9652832
24. Chawla AK Thakral HK Zietman AL Shipley WU Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma: Analysis of efficacy and prognostic factors Urology 2002 59 726-731 10.1016/ S0090-4295(02)01540-6 11992848
25. Cadeddu JA Partin AW DeWeese TL Walsh PC Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy J Urol 1998 159 173-177 10.1016/S0022-5347(01)64047-3 9400465
26. Brooks JP Albert PS Wilder RB Gant DA McLeod DG Poggi MM Long-term salvage radiotherapy outcome after radical prostatectomy and relapse predictors J Urol 2005 174 2204-8, discussion 10.1097/ 01.ju.0000181223.99576.ff 16280764
27. Anscher MS Clough R Dodge R Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: The first 10 years Int J Radiat Oncol Biol Phys 2000 48 369-375 10.1016/S0360-3016(00)00645-3 10974449
28. Cher ML Bianco FJ Jr. Lam JS Davis LP Grignon DJ Sakr WA Banerjee M Pontes JE Wood DP Jr. Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy J Urol 1998 160 1387-1391 10.1016/S0022-5347(01)62545-X 9751361
29. Thomas CT Bradshaw PT Pollock BH Montie JE Taylor JM Thames HD McLaughlin PW DeBiose DA Hussey DH Wahl RL Indium-111-capromab pendetide radioimmunoscintigraphy and prognosis for durable biochemical response to salvage radiation therapy in men after failed prostatectomy J Clin Oncol 2003 21 1715-1721 10.1200/JCO.2003.05.138 12721246
30. Lange PH Lightner DJ Medini E Reddy PK Vessella RL The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels J Urol 1990 144 927-932 1697918
31. Jani AB Blend MJ Hamilton R Brendler C Pelizzari C Krauz L Vijayakumar S Sapra B Awan A Weichselbaum RR Influence of radioimmunoscintigraphy on postprostatectomy radiotherapy treatment decision making J Nucl Med 2004 45 571-578 15073252
32. Shahinian VB Kuo YF Freeman JL Goodwin JS Risk of fracture after androgen deprivation for prostate cancer N Engl J Med 2005 352 154-164 10.1056/NEJMoa041943 15647578
33. Katz MS Zelefsky MJ Venkatraman ES Fuks Z Hummer A Leibel SA Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer J Clin Oncol 2003 21 483-489 10.1200/ JCO.2003.12.043 12560439
34. Partin AW Pearson JD Landis PK Carter HB Pound CR Clemens JQ Epstein JI Walsh PC Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases Urology 1994 43 649-659 10.1016/0090-4295(94)90180-5 7513108
35. Patel A Dorey F Franklin J deKernion JB Recurrence patterns after radical retropubic prostatectomy: Clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen J Urol 1997 158 1441-1445 10.1016/S0022-5347(01)64238-1 9302139
36. Roberts SG Blute ML Bergstralh EJ Slezak JM Zincke H PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer Mayo Clin Proc 2001 76 576-581 11393495
37. Ward JF Zincke H Bergstralh EJ Slezak JM Blute ML Prostate specific antigen doubling time subsequent to radical prostatectomy as a prognosticator of outcome following salvage radiotherapy J Urol 2004 172 2244-2248 10.1097/01.ju.0000145262.34748.2b 15538240
38. Cox JD Gallagher MJ Hammond EH Kaplan RS Schellhammer PF Consensus statements on radiation therapy of prostate cancer: Guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel J Clin Oncol 1999 17 1155 10561174
39. Jani AB Spelbring D Hamilton R Blend MJ Pelizzari C Brendler C Krauz L Vijayakumar S Sapra B Weichselbaum RR Impact of radioimmunoscintigraphy on definition of clinical target volume for radiotherapy after prostatectomy J Nucl Med 2004 45 238-246 14960642
40. Jani AB Blend MJ Hamilton R Brendler C Pelizzari C Krauz L Sapra B Vijayakumar S Awan A Weichselbaum RR Radioimmunoscintigraphy for postprostatectomy radiotherapy: Analysis of toxicity and biochemical control J Nucl Med 2004 45 1315-1322 15299055
41. Morris MM Dallow KC Zietman AL Park J Althausen A Heney NM Shipley WU Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer Int J Radiat Oncol Biol Phys 1997 38 731-736 10.1016/ S0360-3016(97)00080-1 9240639